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Abstract
Background: Hyaluronan (HA) is a non-sulfated glycosamino-
glycan (GAG) that promotes motility, adhesion, and proliferation
in mammalian cells, as mediated by cell-surface HA receptors. We
sought to identify non-carbohydrate ligands that would bind to
and activate cell-surface HA receptors. Such analogs could have
important therapeutic uses in the treatment of cancer, wound
healing, and arthritis, since such ligands would be resistant to
degradation by hyaluronidase (HAse).
Results : Peptide ligands that bind specifically to the recombi-
nant HA binding domain (BD) of the receptor for hyaluronan-
mediated motility (RHAMM) were obtained by screening two
peptide libraries: (i) random 8-mers and (ii) biased 8-mers with
alternating acidic side chains, i.e. XZXZXZXZ (X = all-L-amino
acids except Cys, Lys, or Arg; Z = D-Asp, L-Asp, D-Glu, or L-Glu).
Selectivity of the peptide ligands for the HABD was established by
(i) detection of binding of biotin- or fluorescein-labeled peptides to
immobilized proteins and (ii) fluorescence polarization of FITC-
labeled peptides with the HABD in solution. HA competitively
displaced binding of peptides to the HABD, while other GAGs
were less effective competitors. The stereochemistry of four biased
octapeptides was established by synthesis of the 16 stereoisomers
of each peptide. Binding assays demonstrated a strong preference
for alternating D and L configurations for the acidic residues,
consistent with the calculated orientation of glucuronic acid
moieties of HA.
Conclusions: Two classes of HAse-resistant peptide mimetics of
HA were identified with high affinity, HA-competable binding to
the RHAMM HABD. This demonstrated that non-HA ligands
specific to a given HA binding protein could be engineered,
permitting receptor-specific targeting. ß 2001 Elsevier Science
Ltd. All rights reserved.
Keywords: Glycosaminoglycan-mimicking peptide; High-a⁄nity
ligand; Hyaluronan binding domain; Receptor for hyaluronan-
mediated motility
1. Introduction
The extracellular matrix polysaccharide hyaluronan
(L-1,4-GlcUA-L-1,3-GlcNAc-)n (hyaluronic acid, or simply
HA) is a non-sulfated glycosaminoglycan (GAG) that pro-
motes cell motility, adhesion, and proliferation in mam-
malian cells [1], thereby playing roles in morphogenesis [2],
wound healing [3] and metastasis [4]. These functions are
mediated by cell-surface HA receptors, which initiate key
cell signaling cascades when activated by HA, leading to
physiological changes [4]. Non-carbohydrate ligands that
would bind to and activate cell-surface HA receptors
could have important therapeutic uses in the treatment
of cancer, wound healing, and arthritis, since such ligands
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would be resistant to degradation by hyaluronidase
(HAse). To this end, two peptide libraries were prepared
and screened to identify high-a⁄nity ligands for the HA
receptor RHAMM (receptor for hyaluronan-mediated
motility).
RHAMM mediates cell migration and proliferation in
many normal cells and in tumor cell-lines [5]. Isoforms of
RHAMM are functionally active both in the cytoplasm
and on the cell surface [4]. The extracellular forms of
RHAMM appear to act as co-receptors, which modulate
signaling through integral receptors, such as the PDGF
receptor [6^8]. RHAMM requires the small GTPase p21
ras and pp60 src to promote motility [8,9]. A target of src-
regulated phosphorylation is focal adhesion kinase (FAK)
(pp125FAK), which is an important integrin binding pro-
tein. Phosphorylation of FAK leads to focal adhesion
turnover, a critical step in cell locomotion [10].
RHAMM occurs naturally as a functional HA receptor
in primary human endothelial cells [11] and is overex-
pressed as several isoforms in human tumors and tumor
cell-lines including colorectal [12], breast [13,14], pancre-
atic [15], and multiple myeloma [16]. A dominant negative
mutant of RHAMM, possessing a non-functional HA
binding domain (BD), can block cell transformation by
mutant active ras. Furthermore, overexpression of one
RHAMM isoform constitutively activates the kinase
erk1 (extracellular signal-regulated protein kinase) [7]
and is transforming in ¢broblasts [10]. RHAMM occurs
as an intracellular protein but can be expressed on the cell
surface, a condition observed most often in single cells
such as leukocytes [17,18] and in subcon£uent ¢broblasts
[7]. Cell-surface RHAMM binds to extracellular HA and
the HA^RHAMM complex undergoes receptor-mediated
endocytosis [19]. Intracellular RHAMM binds to cytoskel-
etal proteins [20] and associates with proteins in the erk
kinase cascade [7].
Mutational analysis of RHAMM identi¢ed two regions
near the C-terminus that are required for full HA binding
[21]. These regions have clusters of basic residues and have
a so-called BX7B motif (B = basic residue, X = any non-
acidic residue) present in several HA binding proteins
[22]. Synthetic peptides representing the RHAMM do-
mains inhibit HA binding to full length RHAMM, while
peptides representing other parts of the primary sequence
fail to inhibit binding [21]. RHAMM has one of the high-
est densities of basic residues of any HA receptor. CD44
and other link module-containing proteins may have the
BX7B motif, but these HABDs are architecturally and
functionally distinct [23]. Although RHAMM is known
to bind heparin at the same binding site as HA [24], no
other GAGs have been reported to bind to RHAMM with
high a⁄nity.
The secondary structure of RHAMM is predicted to be
predominantly helical. The structure of the HABD was
recently studied using multi-dimensional nuclear magnetic
resonance (NMR) and was observed at 3 Aî resolution to
be a helix-loop-helix with a coiled-coil tertiary structure
[25]. This contrasts with the L-sheet-containing link mod-
ule of the protein TSG-6 [26,27]. Using RHAMM num-
bering [28], the N-terminal of the HABD is completely
contained within a loop (residues 531^539), while the sec-
ond half of the domain (residues 553^562) spans a loop
and a helical region. The interaction of HA with HABDs
requires both electrostatic interactions between the glucu-
ronate carboxylates and basic residues of the protein, as
well as potential hydrophobic interactions involving me-
thine patches on HA [27].
In this study, two synthetic peptide libraries, one com-
posed of random octapeptides and one containing alter-
nating acidic and non-acidic residues, were examined for
potential non-GAG ligands for the HABD. These one-
bead, one-peptide libraries [29] were screened with the
RHAMM^HABD in order to identify high-a⁄nity pep-
tides for the HABD. The biased acidic library was de-
signed to mimic the natural pattern of alternating glucu-
ronic acid carboxylates present in HA; this represents the
¢rst rational approach to identi¢cation of a non-GAG li-
gand for a HA binding site. Importantly, this library in-
cluded both natural and unnatural con¢gurations of the
acidic residues to further explore possible oligosaccharide
conformations that could be important in ligand recogni-
tion.
This paper will present three major results. First, recur-
ring peptide motifs that bind to HABDs were identi¢ed in
both biased and random libraries. Second, solid-phase
binding and £uorescence polarization (FP) assays were
developed to quantify the relative a⁄nity and selectivity
of peptide^RHAMM interactions. Third, the importance
of including acidic amino acids with unnatural con¢gura-
tions was demonstrated. A molecular model based on
minimized structures of the active enantiomeric peptides
suggested that the staggered carboxylate orientation rela-
tive to the peptide backbone is similar to the carboxylate
orientation in HA.
2. Results
2.1. Initial library screening
A solid-phase method was employed to con¢rm that
RHAMM HABD-containing proteins would bind to bio-
tinylated HA (bHA), based on earlier methods used for
bHA^HABD studies [30,31]. To this end, a dot blot of
puri¢ed glutathione S-transferase (GST)^RHAMM(518^
580), GST, and RHAMM(518^580) on polyvinyl di£uo-
ride (PVDF) membrane was employed, since the highly
basic, small RHAMM(518^580) polypeptide itself failed
to electrotransfer to PVDF. GST^RHAMM(518^580)
and RHAMM(518^580) bound bHA, but neither GST
alone nor bovine serum albumin (BSA) bound bHA
(data not shown). Comparison of electrotransferred pro-
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teins on PVDF with electrophoretically separated GST^
RHAMM(518^580) and thrombin-cleaved GST^
RHAMM(518^580) (only GST remained) showed that
the fusion protein could be detected with bHA (data not
shown) while GST alone could not. Similarly, thrombin
cleavage of GST^RHAMM(518^580) in a 96-well plate
released the HABD, which was detected using a dot
blot. These control experiments demonstrated the speci¢c-
ity of HA binding to RHAMM(518^580) and not to the
GST domain.
Two eight-amino acid libraries were synthesized on 100-
Wm Tentagel beads and screened using GST^
RHAMM(518^580) as the HABD. Library R contained
completely random sequences of 19 L-amino acids (exclud-
ing Cys), while Library B consisted of alternating acidic
residues in an XZXZXZXZ pattern. For Library B, the
acidic (Z) residues were allowed to have either the natural
L or unnatural D absolute con¢guration. The synthesis
generated three million beads for each library; typically,
an aliquot of ca. 100 000 beads was used for each screen.
The number of beads was determined by the practical
limits of the experimental approach, and by the calcula-
tion that this number should adequately represent the di-
peptide or tripeptide motifs that were anticipated in an
octapeptide population. Thus, starting with 100 000 beads,
approximately 30 positive ‘blue’ beads were identi¢ed after
three rounds of screening. The ¢nal round of screening
included a competition step with HA to block peptide
binding to the HABD; positive beads in this step were
‘white’. Table 1 also summarizes the peptides directly se-
quenced following screening of Libraries R and B with
GST^RHAMM(518^580). Approximately half of the pos-
itive beads were sequenced, and of these, 20% of the se-
quencing attempts failed for technical reasons. A single
‘white’ bead from the ¢rst screening was selected as a
negative control ; peptide NB had the sequence IDSD-
WEGE.
2.2. Deconvolution of Library B hits
Since Library B was synthesized with either the D- or
L-isomers at the alternating acidic residues, it was neces-
sary to deconvolve the particular combination of natural
and unnatural amino acids in each positive hit. Solid-
phase synthesis on each bead created one of 16 possible
diastereoisomers of a given ‘letter’ sequence, correspond-
ing to a total of two enantiomers at each of four positions.
Using automated Edman degradation for peptide sequenc-
ing, the chirality of the PTH amino acid sequenced at any
given cycle could be determined. Prior to Wmol-scale syn-
thesis of peptides to determine binding a⁄nities, the dia-
stereomeric ambiguity was ¢rst resolved by construction of
a mini-library of the 16 individual diastereomers of the
Library B peptides. This peptide mini-library was con-
structed as an array of spots on a cellulose membrane
(Pepspots0), in which each spot contained a single diaste-
reomer of the Library B peptide letter sequence (3^5 nmol/
spot). The membrane mini-library was prepared commer-
cially, and consisted of an array of 72 spots: 16 diaste-
reomers of peptides B-1, B-2, B-3, and B-4, four negative
control spots (using the sequence of a non-binding nega-
tive control, IDSDWEGE), and four spaces between each
set of 16 diastereomers.
GST^RHAMM(518^580) binding to the Pepspots0
mini-library was carried out by semi-dry transfer in order
to permit use of the original membrane for multiple pro-
tein-stripping and reprobing experiments. Thus, GST^
RHAMM(518^580) was incubated with the blocked
Pepspots0 membrane and speci¢cally bound protein was
transferred to a PVDF membrane. Bound GST^
RHAMM(518^580) was detected using goat anti-GST,
followed by anti-goat IgG horseradish peroxidase
(HRP)-conjugated antibodies. Binding was visualized and
quanti¢ed (Fig. 1) with a chemiluminescent HRP sub-
strate. These data allowed selection of speci¢c diastereo-
mers of Library B peptides to analyze binding of a single
homogeneous species rather than a diastereomeric mix-
ture. Four pairs of diastereomers with ca. 100-fold binding
di¡erences were synthesized and used as described below
to measure binding a⁄nities for the RHAMM HABD (see
Table 2).
The data in Fig. 1 illustrate that peptide diastereomers
containing only L-Glu and L-Asp do not exhibit the opti-
mal a⁄nity. This most likely re£ects the importance of the
orientation of the carboxylate-containing side chains. With
a combination of D- and L-amino acids in a single peptide,
the structures with carboxylates on alternating ‘sides’ of
the peptide more closely imitate the orientation of the
glucuronate carboxylates in HA. The B-1, B-3 and B-4
series demonstrate this clearly, in that the all-L-peptide
exhibits no observable binding. The all-L-peptide in B-2
bound with lower a⁄nity than diastereomers containing
a single D-Asp or D-Glu residue. This suggests that one
component of binding is derived from the hydrophobic
Table 1
Sequences of HA-mimetic peptides
Random Biased
R-1 SGRPYKPP B-1 MDYEPEQE
R-2 YXSSNKPG B-2 YDSEYESE
R-3 EGEWPVYP B-3 FDFDSEYE
R-4 WNYTEAKG B-4 EDAENDEE
R-5 QAMNKFTF
R-6 NTDSNKNM NB IDSDWEGE
R-7 NPVFNDGY
R-9 FLRWFIMI
R-10 EMAQMLLE
R-11 PFLMKFPI
R-12 IYIYPQPQ
Peptide sequences were obtained by direct Edman degradation using
positive library beads screened with RHAMM(518^580). Peptide NB se-
quence was obtained from a negative control (non-binding) bead se-
lected from the ¢rst round of screening of Library B.
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repeats as well as charge orientation. Similarly, the aro-
matic residue-rich B-3 peptides showed robust binding to
the HABD, as favored by the ‘opposite side’ carboxylate
orientation. Hydrophobic and aromatic-rich patches on
HA have been implicated in stabilizing HA secondary
structure [32,33] and in HA^HABD interactions [23,34].
2.3. A⁄nities of peptides for RHAMM HABD
Three microplate binding assays were employed to mea-
sure the a⁄nity of synthetic peptides for RHAMM(518^
580): enzyme-linked immunosorbent assay (ELISA), a
£uorescence-based analog of the ELISA, and FP. The
ELISA required a biotinylated peptide, while both the
£uorescence-based solid-phase and the FP assays required
a £uorophore-modi¢ed peptide. Thus, two thiol-reactive
maleimide reporter groups were used, requiring an N-ter-
minal cysteine for probe attachment. For competition as-
says with probe-modi¢ed peptides or bHA, peptides lack-
ing the Cys residue were also required. These were
conveniently prepared by removal of half of the synthetic
peptide from the synthesizer prior to addition of the ¢nal
Cys residue. Synthetic peptides from each sub-group of
similar peptides of Library R were prepared (see Table
1). For Library B, each of the four positive peptides con-
taining both D- and L-acidic residues, as identi¢ed by the
Pepspots0 deconvolution experiment, were synthesized.
The binding a⁄nities of the synthetic peptides were
measured with the ELISA method as described in Section
5, and KD values were determined mathematically [35]. In
a typical experiment, the KD for a given biotinylated pep-
tide was determined using successive ¢ve-fold dilutions of
probe and using a ¢xed amount of immobilized protein.
Experiments were performed in triplicate with background
(no protein) subtraction prior to calculations. The stoichi-
ometry of binding was determined using a standard curve
of streptavidin (SA)^HRP serial dilutions. For example,
R-3, one of the highest a⁄nity random peptides, had a
Fig. 1. Deconvolution of Library B diastereoisomers. Uppercase letters represent the natural L-con¢gurations and lowercase letters represent the
D-con¢gurations of Glu (E, e) and Asp (D, d). Peptides were synthesized as 5 nmol ‘Pepspots0’ and transferred to PVDF as described in the text. A
chemiluminescence assay with a HRP-labeled secondary antibody was used to detect GST^RHAMM(518^580) bound to each peptide spot. The
intensity of each spot was quanti¢ed with NIH Image software. Data shown are from a single ¢lm, but the results were validated from three blots.
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Table 2
Binding a⁄nities for synthetic HA-mimetic peptides
Name Sequence Binding displaced by HA (%) KD from plate assay (nM) KD from FP (nM)
Library B
B-1A CMdYEPeQe 33 þ 5 49 þ 3 17 þ 5
B-1B CMDYePEQe 61 þ 8 73 þ 5 nd
B-2A CYDSeYeSe 76 þ 5 8 þ 1 nd
B-2B CYDSEYeSE 78 þ 8 74 þ 8 nd
B-3A CFDFdSEYe 86 þ 7 730 þ 25 nd
B-3B CFdFdSEYE 67 þ 10 1400 þ 200 nd
B-4A CEDAeNdEe 37 þ 8 110 þ 13 nd
B-4B CEdAENdEe 53 þ 5 499 þ 75 220 þ 58
Library R
R-3 CEGEWPVYP 67 þ 5 48 þ 2 nd
R-5 CQAMNKFTF 58 þ 5 270 þ 45 nd
R-12 CIYIYPQPQ 75 þ 9 5300 þ 85 nd
An N-terminal Cys was added to each bead-derived sequence to permit attachment of reporter groups. The KD values from the plate assay were ob-
tained using the solid-phase ELISA using N-terminally biotinylated peptides as described in the text. Competitive displacement was determined by pre-
incubation of RHAMM^HABD with 1 mg/ml of 4^40 kDa HA. In the amino acid sequences, uppercase letters represent the natural L-con¢gurations
and lowercase letters represent the D-con¢gurations of Glu (E, e) and Asp (D, d). Key: nd = not determined.
Fig. 1 (Continued).
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KD value of 48 nM with a 1:1 binding ratio; biased pep-
tide B-2A had a KD value of 8 nM. The binding a⁄nities
are summarized in Table 2.
2.4. Domain selectivity and competitive displacement of
peptide binding by GAGs
The ELISA was modi¢ed to address selectivity of bind-
ing. Thus, a domain selectivity and a GAG competition
assay were each conducted using a modi¢cation of the
solid-phase ELISA that allowed use of £uorescein-labeled
peptides. Although the data from this modi¢cation are less
accurate for absolute quantitation, a lower background
could be achieved as compared to the SA^HRP ELISA
method. First, we demonstrated that RHAMM HABD,
not the GST fusion partner, was responsible for peptide
binding. Peptides from the two libraries were evaluated.
Fig. 2 illustrates that the majority of peptides show negli-
gible binding to the GST domain. It is possible that the
£uorophore modi¢cation could increase the non-speci¢c
binding beyond that detected in the original library screen-
ing protocols.
Second, we evaluated the e¡ectiveness of several GAGs
to inhibit binding of synthetic peptides to the HABD of
RHAMM. HA was used as a competitor for all synthetic
peptides, and other GAGs were evaluated with a subset of
peptides. Fluorescein-labeled peptides representing each of
the libraries were added to ELISA plates containing im-
mobilized GST^RHAMM(518^580) that had been pre-in-
cubated with 4^40 kDa HA, and washed to remove excess
ligand. Fig. 3a shows the competitive displacement of pep-
tide binding to GST^RHAMM(518^580) by HA for six
selected peptides. In all but one instance, 0.1 mg/ml of
the 4^40 kDa HA provided optimal competition of the
Fig. 3. a: Competitive displacement of six selected £uorescein-labeled peptides (B-2A, B-2B, B-3A, B-3B, R-5, and R-12) by HA using the solid-phase
£uorescence binding assay. The concentration of 4^40 kDa HA was 0.1 mg/ml, except for B-2A, for which 1 mg/ml of 4^40 kDa HA was used.
b: Competitive displacement of biotinylated peptide binding to GST^RHAMM(518^580) by HA and three sulfated GAGs using the solid-phase colori-
metric ELISA for four selected biotinylated peptides (B-1A, B-2A, R-5, and R-12). Key: HEP, heparin; CS-A, chondroitin 4-sulfate; CS-C, chondroitin
6-sulfate.
Fig. 2. Binding of nine £uorescein-labeled peptides to GST^RHAMM(518^580) and GST alone using the solid-phase £uorescence binding assay.
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peptide. For the highest-a⁄nity peptide B-2A, 1 mg/ml of
4^40 kDa HA was necessary to compete for peptide bind-
ing. Fig. 3b illustrates the relative competitive displace-
ment by HA and three sulfated GAGs for four selected
peptides; in this ELISA assay, the biotinylated peptides
were employed in conjunction with the SA^HRP reporter
system. The data in Fig. 3b show an overall higher back-
ground than those in Fig. 3a as a result of additional non-
speci¢c interactions from the secondary ELISA detection
system. The non-speci¢c interactions of both HA and
chondroitin sulfate (CS) with BSA are well known
[36,37]. The colorimetric detection system was used for
experiments in Fig. 3b rather than £uorescence to be con-
sistent with the binding assay used for the majority of the
peptide binding. The di¡erences in competition between
CS-A and CS-C are noteworthy, since these 4-sulfate
(CS-A) and 6-sulfate (CS-C) regioisomers of CS interact
di¡erently with di¡erent HA binding proteins [14,38^40].
Preliminary data from our laboratories indicated that CS-
A showed modest, but higher a⁄nity to RHAMM than
CS-C.
2.5. FP assays to verify solid-phase binding results
The data from the solid-phase binding assays were sup-
plemented by a second methodology. FP measures the
change in anisotropy of a £uorescent probe in free and
bound states [41^43]. An increase in anisotropy is propor-
tional to the ligand^protein complex formation; this assay
is independent of £uorescence intensity. Using a ¢xed con-
centration of each £uorescein-labeled peptide, increasing
concentrations of the RHAMM^HABD were added to a
96-well plate optimized for low-background £uorescence
measurements. The concentrations were chosen so that
the measurements span the range from 0.01UKD to
100UKD. Fig. 4 illustrates the primary data for peptides
B-1A (17 þ 5 nM), and B-4B (220 þ 58 nM), which showed
a⁄nities of 49 nM and 499 nM, respectively, in the ELISA
assay. This correlation validated the FP assay for use in
measuring peptide^protein interactions for HA-mimicking
peptides. However, due to the multivalent nature and vis-
cosity-altering properties of HA, it was not practical to use
the FP assay for competitive displacement experiments.
3. Discussion
The importance of RHAMM in cell motility and meta-
static progression [12,13] provided the impetus to identify
potential non-GAG ligands that could serve as HAse-re-
sistant HA surrogates in basic research and as leads for
drug design. We sought ligands that could speci¢cally tar-
get the HABD of RHAMM but would not be recognized
by other hyaladerins such as CD44 and link protein. We
reasoned that peptide mimics can explore conformations
and chemical functionalities unavailable to natural GAG
ligands. Consequently, peptide mimics could achieve novel
selectivities for binding to, and activation of, di¡erent HA
receptors. To this end, two peptide libraries were screened
using the HABD of RHAMM as bait for octapeptides
with high a⁄nity and selectivity. Both libraries a¡orded
high-a⁄nity ligands that acted as HA surrogates, as deter-
Fig. 4. Binding curves and Scatchard analyses of FP measurements of GST^RHAMM(518^580) with peptides B-1A and B-4B.
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mined by three in vitro binding assays. Library B, which
contained alternating acidic residues, was inspired by the
alternating pattern of glucuronic acid and N-acetylglucos-
amine that characterizes the linear HA structure. More-
over, we anticipated that nucleophile-rich residues would
be commonly found in the HA-mimetic peptides identi¢ed
by this screen. In contrast, we identi¢ed common motifs in
which hydrophobic residues predominated in Library R, a
bead-based library of random octamers. This unexpected
result was nonetheless consistent with the observation that
HA can interact with aromatic-rich patches on another
HA binding protein, the link module of human TSG-6
[34]. Thus, the two di¡erent peptide libraries provided
both rational and unbiased approaches to ligand identi¢-
cation.
3.1. The random bead library has tripeptide motifs
Three recurring dipeptide or tripeptide motifs were
noted in Library R : (i) the PVu motif, where u is F or
Y, was present in R-7 and R-3 ; (ii) the QAM motif was
present in R-5 and in retrograde form in R-10 ; and (iii) the
Pu/uP dipeptide sequence was found in R-1, R-11, and
R-12 (Table 3). Of these random library-derived ligands,
the peptide with the highest a⁄nity for RHAMM-
(518^580) was R-3 (EGEWPVYP) with an apparent KD
value of 48 nM. Interestingly, the negative control peptide
NB (IDSDWEGE) shared the EGE tripeptide, which thus
appeared not to participate in binding; this provided addi-
tional support for the importance of the PVu motif in
binding to RHAMM. Moreover, R-3 contained a Pu/uP
motif, which could further enhance the a⁄nity of this
peptide.
Since the structure of the RHAMM(518^580) showed
the HABD to be a surface-exposed domain [25], peptide
binding could be governed by a short motif ; this would
account for the sequence diversity within the peptide li-
gands identi¢ed. In addition, di¡erences in solubility and
elements of secondary structure could a¡ect relative bind-
ing a⁄nities. It is surprising that few peptides were repre-
sented in both libraries. Only one Library R peptide
showed the acidic-X-acidic motif imposed synthetically
on the Library B, and in that example, the EGE may
not even be important for binding. The results from the
Library B peptides and the importance of alternating ab-
solute con¢gurations of the acidic side chains can account
for this apparent paradox, as described below.
The Pu/uP motif also occurred in peptides screened with
the link module-containing HA binding protein TSG-6
[26]. TSG-6 is a 275-amino acid secretory protein involved
in cell^cell and cell^matrix interactions during in£amma-
tion [44], and a three-dimensional solution structure of the
HA binding link module has been determined by NMR
[26]. None of the peptides obtained with this structurally
di¡erent ‘bait’ protein bound to GST^RHAMM(518^580),
and these data will be presented in due course (M.R. Zie-
bell, A.J. Day, and G.D. Prestwich, unpublished results).
3.2. Precedent for alternating charged D- and L-amino acids
in the biased library
The rationale for synthesizing Library B with alternat-
ing acidic amino acids was to mimic the alternation of
glucuronic acids of HA, in both the linear and three-di-
mensional distribution of charge. The glucuronic acid moi-
eties of HA are separated by approximately 10 Aî [45],
with a dihedral angle between 3110‡ and 3167‡, indicat-
ing that they protrude from opposite faces of a plane that
approximates the linear sequence of sugars. Since these
charge repeats appear to be important in HA^protein in-
teractions, Library B was designed to detect peptides with
alternating carboxylates with high a⁄nity for RHAMM^
HABD. To this end, Library B was prepared with either
D- or L-enantiomers of Glu or Asp in the acidic residue
position.
A non-optimized model of a random coil peptide sug-
gested that alternating acidic residues should give a pat-
tern of negative charges separated by approximately 10 Aî .
A model was thus constructed based on diastereomers
discovered from the library screen. The peptides B-2 (YD-
SEYESE) and B-2B (YDSEYeSE) were modeled using
InsightII (Molecular Simulations, Inc.). From a family
of 10 conformers, each minimized and subjected to a rou-
tine molecular dynamics protocol, a marked di¡erence in
the orientation of the acidic side chains was apparent (Fig.
5). The average distance between Glu4 HE2 and Glu6
OE1 for B-2 was 6.11 þ 1.72 Aî , while for B-2B this dis-
tance was 12.56 þ 1.47 Aî . The averages of the absolute
value of the dihedral angles between Glu4 and Glu6 side
chains were 41.9 þ 29.6‡ for B-2 and 129.5 þ 44.2‡ for
B-2B. These parameters suggest that a peptide with alter-
nating acidic residues, one with D con¢guration and one
with L con¢guration, should most closely mimic HA. The
results of this series of minimizations are graphically rep-
resented in Fig. 5, where each point represents the mini-
Table 3
Alignment of random peptide sequences showing tri- and dipeptide mo-
tifs
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mized distance between the two protons. Fig. 6 illustrates
three structures obtained from the molecular modeling
experiments. Coordinates for HA (Fig. 6, top) were ob-
tained from the Protein Databank (accession no. 4HYA)
[45] with the glucuronic acid sugar residues highlighted.
The calculated structures for the all-L-con¢guration octa-
peptide B-2 (center) and the peptide with a single D-con-
¢guration side chain B-2B (bottom) showed the distance
and angular relationships between acidic side chains. In
the minimum energy conformer for B-2, these constants
poorly imitated HA; in contrast, the minimum energy
conformer for B-2B more adequately approximated the
spatial and angular measurements of a HA oligosaccha-
ride.
3.3. The biased library favors unnatural acidic residues
A number of high-a⁄nity ‘hits’ were sequenced from
beads in Library B. However, even though each hit was
a unique molecular species, the Edman degradation could
not provide information on the absolute con¢guration of
the particular linear sequence obtained. Thus, each se-
quence represented 16 possible molecular structures. De-
convolution was accomplished by synthesis of each of the
16 diastereomers of three Library B peptides using the
commercial Pepspots0 technology. The strongest binding
peptides from the biased library were speci¢c diastereom-
ers of peptides B-1 (MdYEPeQe, peptide B-1A) and B-2
(YDSeYeSe, peptide B-2A) ; D-amino acids are indicated
with lower case letters. Peptides with alternating D- and L-
acidic residues showed the highest a⁄nity. The ‘anti’ rela-
tionship appeared to most closely re£ect the angular ori-
entation of carboxylates on HA, consistent with the model
used to design these HA-mimetic peptides. In Library B,
we deliberately created a pattern of charges within each
octapeptide. While many octapeptides bound with high
a⁄nity to the RHAMM HABD, charge distribution was
not the only factor dictating binding a⁄nity, as previously
observed for Library R peptides.
Small aromatic residues (Tyr or Phe) and Ser residues
were abundant in Library B, e.g. B-2 (YDSEYESE) and
B-3 (FDFDSEYE). The aromatic residues may mimic the
putative hydrophobic patches of HA. In peptides with
alternating D- and L-acidic side chains as well as Tyr,
Phe, or Ser (e.g. peptide B-3A, FDFdSEYe), the random
Fig. 6. Molecular model showing calculated minimum energy structures
for HA (top), peptide B-2, YDSEYESE (middle, all-L-amino acids), and
peptide B-2B, YDSEYeSE (bottom), which contains a single D-Glu resi-
due. The carboxylate to carboxylate distances are indicated by double-
headed arrows in each energy-minimized structure.
Fig. 5. Summary of 10 molecular dynamics and minimization routines
on peptides B-2 and B-2B. The distance is measured between Glu4 HE2
and Glu6 OE1 on either peptide. The modeling was performed using
Discover and included 1000 iterations of minimization runs using an
Amber force ¢eld. The dynamics routine had 10 000 steps including
charge and Morse terms.
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coil conformation predicts that the polar and non-polar
side chains would be oriented at a 180‡ dihedral angle.
The formation of a hydrophobic surface consisting of
two phenyl rings could re£ect the conformation of HA
in which the eight methines on the hydrophobic face
span three sugar residues. Modeling of these peptides
into a three-dimensional model of RHAMM is in progress
[25].
In summary, a fusion protein was generated that con-
tains a 62-amino acid polypeptide comprising the HABD
of RHAMM [46]. This RHAMM construct was shown to
have HA binding activity and the puri¢ed protein had
de¢ned secondary and tertiary structures [25]. Using this
HABD as ‘bait’, two peptide libraries were screened for
molecules that speci¢cally target the HABD of RHAMM.
Several of the peptide hits that were identi¢ed and se-
quenced were then synthesized and evaluated to determine
their a⁄nity and speci¢city in binding to RHAMM. Many
of these peptides bound to RHAMM with high a⁄nity,
and competition by HA or other GAGs suggested that the
peptides were directed to the HABD.
4. Signi¢cance
We have identi¢ed two classes of HAse-resistant peptide
mimetics of HA that exhibit high-a⁄nity, HA-competable
binding to RHAMM, a receptor important in cell motility,
adhesion, and proliferation and implicated in the pathol-
ogy of cancer. These peptides may serve as antagonists
that could block the transforming potential of RHAMM.
In related work, we also identi¢ed a number of 15-mer
peptides by phage display that bind with high a⁄nity to
RHAMM(518^580) and a¡ect cell physiology and erk1^
RHAMM interactions [47]. In an analogous experiment,
phage-derived peptides that bound the CTLA4 receptor
were found to activate T-cells [48].
Peptides that mimic HA could also be useful for drug
targeting. The problem of directing anti-cancer agents to
tumors remains one of the technological barriers to devel-
oping e¡ective therapies for cancer treatment [49]. The
overexpression of RHAMM on cancer cells relative to
normal epithelial cells provides an opportunity for tu-
mor-speci¢c drug targeting. HA-conjugated anti-tumor
agents [50] and other drugs [51] often lack speci¢city for
a particular class of HA receptors.
Either as therapeutics or targeting moieties, HA-mi-
metic peptides o¡er several unique properties. First, the
peptides are resistant to HAse degradation. Second, pep-
tides can act as antagonists rather than agonists. Third,
peptides can be selected that would not be recognized by
liver endothelial cell receptors involved in HA clearance
from circulation [52]. Fourth, peptides could be selected to
be speci¢c for RHAMM isoforms or CD44 isoforms
present in pathological situations.
5. Materials and methods
5.1. Sub-cloning of RHAMM(518^580) into PGEX-2T
The RHAMMv4 cDNA in a pCRII vector [10] was used as a
template for PCR production of the RHAMM constructs. Se-
quence-speci¢c primers encoded restriction sites to permit ligation
of PCR products into the appropriate vectors. Thus, the
RHAMM(518^580) PCR product was digested, puri¢ed, and li-
gated directly into PGEX-2T (Pharmacia) using unique EcoRI
and BamHI restriction sites. Initial ligation of PCR products
into a PGEM-T vector (Novagen) improved the ligation e⁄-
ciency. Plasmid and PCR insert puri¢cation followed standard
protocols, and DNA was puri¢ed by either phenol^chloroform
extraction [53] or with Qiagen columns.
5.2. Puri¢cation of GST fusion protein
GST^RHAMM(518^580) (RDSYAQLLGHQNLKQKIKHV-
VKLKDENSQLKSEVSKLRSQLVKRKQNELRLQGELDKA-
LGIR) [28,46], with BX7B motifs underlined, was expressed in
BL21 Escherichia coli cells in ampicillin-containing media by in-
duction with IPTG (2 mM). Cells were harvested by centrifuga-
tion at 2000Ug for 30 min, resuspended in phosphate-bu¡ered
saline (PBS) with 30 Wg/ml leupeptin and 1 mM PMSF, and lysed
using a French press at 20 000 psi. Triton X-100 (1% ¢nal con-
centration) was added to the lysate, incubated on ice for 30 min,
and centrifuged at 12 000Ug for 30 min. The brown supernatant
was applied to 10 ml of glutathione Sepharose equilibrated in
PBS at 4‡C, the column was washed with 15^20 ml of PBS at
1 ml/min, and the GST^RHAMM(518^580) was eluted with 50
mM glutathione, 10 mM Tris, pH 8.0. Glycerol was added to
10% ¢nal concentration, and 1.5-ml aliquots of puri¢ed protein
were £ash frozen on dry ice and stored at 330‡C. Then, a sample
was thawed in ice water and diluted to the required concentration
in Tris-bu¡ered saline (TBS). Unused protein from a thawed
aliquot was discarded; no loss of activity was noted for a single
freeze-thaw cycle.
5.3. Synthesis of bHA
bHA was prepared using the hydrazide method [54,55]. Bacte-
rially expressed HA (100 mg, 0.25 mmol disaccharide equivalents,
molecular weight 700 000) (Clear Solutions Biotech, Inc., Stony
Brook, NY, USA) was dissolved in 20 ml of water by stirring
vigorously overnight. To obtain ca. 5% modi¢cation of carboxyl
groups (0.0125 mmol), 18.6 mg of biotin-LC-hydrazide (Pierce,
Rockford, IL, USA) dissolved in 180 Wl dimethylsulfoxide
(DMSO) was added, followed by 24 mg (0.125 mmol) of 1-[3-
(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride. The
bHA was puri¢ed by extensive dialysis over several days, alter-
nating between 500 mM NaCl and water [56].
5.4. bHA blot method
PVDF membranes (Bio-Rad) were pre-wetted in MeOH and
then 3^5 Wl of the protein was added dropwise as the MeOH
evaporated. After the membrane absorbed the protein solution,
it was immediately immersed in blocking bu¡er (TBS+1% poly-
vinyl pyrrolidone (PVP-40) and 1% casein) for 2 h. The mem-
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brane was then incubated with 10 Wg/ml of bHA in blocking
solution for 2 h, washed three times with TBS-T, incubated
with 1:4000 dilution of SA^HRP for 40 min, washed, and visu-
alized after a 60 s incubation with BM chemiluminescent ELISA
substrate (Boehringer Mannheim). The membrane was covered
with plastic wrap and immediately exposed to X-ray ¢lm (X-
Omat-AR ¢lm, Kodak). The signal was quanti¢ed with a com-
puter-controlled scanner (UMAX 1200S), and the digitized signal
was analyzed using NIH Image.
5.5. Construction of the peptide libraries
Two eight-amino acid one-bead, one-peptide libraries were
constructed [57]. Library R was a completely random library in
which only cysteine was omitted during synthesis. Library B had
an alternating acidic pattern, XZXZXZXZ, with X = any residue
except Cys, Arg, or Lys, and Z = D-Asp, L-Asp, D-Glu, or L-Glu.
Thus, Tentagel S NH2 beads (Rappe Polymere GmbH, Tu«bingen,
Germany) are 80^100 Wm in diameter with 0.3 mmol reactive
amine/g dry weight [57,58]. A typical starting sample size was
six million beads, which were incubated with 9-£uorenylmethoxy-
carbonyl (Fmoc)-protected amino acids whose free carboxyls
were activated with 1-hydroxybenzotriazole and o-benzotriazol-
1-yl-N,N,NP,NP-tetramethyluronium hexa£uorophosphate (Ad-
vanced Chemtech, Louisville, KY, USA). The reaction proceeded
in dimethylformamide (DMF) and the beads were puri¢ed at
each step by washing with DMF. The Fmoc-protected amine
was deprotected using 20% piperidine in DMF and quantitative
analysis determined the amount of available amine. To ensure a
completely random library for Library R, the following strategy
was used. The entire batch of beads was split into 19 equal pools,
each in a separate plastic column. Each batch was allowed to
react with a single variety of Fmoc amino acid followed by a
DMF wash. All beads were then combined, mixed, and then
separated again into 19 new pools, and the process was repeated
eight times. This method ensures the presence of a random pop-
ulation of peptides, while only one species is attached per bead.
An analogous split-pool-split procedure was performed for Li-
brary B, alternating between a four-pool split and a 17-pool split.
5.6. Bead screening
Beads (2 ml, approximately 2U105 beads) from Library B or
Library R were placed in a 5-ml plastic column (Bio-Rad) and
pretreated by washing with decreasing concentrations of DMF in
TBS and ¢nally with TBS containing 0.1% PVP-40. Next, 1 ng/ml
of GST^RHAMM(518^580) was incubated with the beads for 1 h
at room temperature on an orbital shaker. The beads were
washed with 20 column volumes of bu¡er, and incubated with
a 1:5000 dilution of anti-GST. This washing was repeated, fol-
lowed by incubation with a 1:10 000 dilution of anti-goat IgG
alkaline phosphatase. After extensive washing, the beads were
then incubated with 0.27 mM 5-bromo-4-chloro-3-indolyl phos-
phate in detection bu¡er (TBS+2 mM MgCl2). The positive beads
turned blue within 10^30 min, and were then sorted under 100U
magni¢cation using a syringe ¢tted with a 10-Wl pipette tip. The
beads were stripped of bound protein and color by washing with
6 M guanidinium hydrochloride, pH 2.5, followed by three
washes with DMF. This screening process was repeated three
times, with the total number of beads decreasing after each suc-
cessive screen. The ¢nal screen included a pre-incubation step
with 1 mg/ml digested HA as competitor, such that beads that
did not turn blue in the ¢nal screen were candidates for binding
to the HABD of RHAMM.
Peptides on beads were sequenced by placing a single bead on
a ¢lter in the same manner that a polypeptide in solution would
be immobilized. Sequencing was accomplished using Edman
degradation chemistry on an Applied Biosystems Model 477A
Gas Phase Peptide Sequencer. A single ‘white’ bead from the
¢rst screening was selected as a negative control, designated
peptide NB, and its sequence was determined to be IDSD-
WEGE.
5.7. Pepspots0 analysis of biased library results to determine
chirality of peptides
Each of the 16 possible diastereomers for four positive Library
B peptides was synthesized in spots immobilized on cellulose
(Pepspots0, Jerini Biotools, Wilmington, NC, USA). Four dia-
stereomers of the negative control peptide NB (IDSDWEGE)
were also synthesized. The amount of immobilized peptide is
reported to be 3^5 nmol on the membrane as a 2-mm dot.
Binding to the Pepspots0 was detected by incubation of the
blocked (TBS+0.1% casein) membrane with 50 Wg/ml GST^
RHAMM(518^580) in blocking bu¡er. After washing, the bound
protein was semi-dry electrotransferred from the cellulose mem-
brane onto a PVDF membrane using the Phast (Pharmacia) sys-
tem. A system of three bu¡ers recommended by Jerini Biotools
was used in this transfer: cathode bu¡er (25 mM Tris, 40 mM
6-aminohexanoic acid, 0.01% sodium dodecyl sulfate and 20%
methanol) ; anode bu¡er I (30 mM Tris base, 20% methanol);
and anode bu¡er II (300 mM Tris base, 20% methanol). Filter
paper squares were soaked in these bu¡ers, three sets for each
membrane to be transferred. First, the anode bu¡er I-soaked
¢lter papers were placed on the anode, followed by the anode
bu¡er II-soaked membranes; the two membranes were arranged
with the PVDF membrane on the anode side of the cellulose
membrane. The sandwich was completed with the cathode bu¡-
er-soaked ¢lter papers. The cathode was placed on top of the
sandwich and the transfer was performed at 0.8 mA/cm2 of mem-
brane for 40 min at 4‡C.
The PVDF membrane with the blotted GST^RHAMM(518^
580) was blocked and incubated with a 1:5000 dilution of anti-
GST, followed by a 1:10 000 dilution of anti-goat antibody^
HRP. To detect bound material, a chemiluminescence detection
kit (Boehringer Mannheim) was used followed by exposure to
¢lm. The developed ¢lm was scanned and quanti¢ed as above.
Each experiment was repeated several times with di¡erent
GST^RHAMM(518^580) concentrations; increased GST^RHA-
MM(518^580) concentrations resulted in increased background
and non-speci¢c binding.
5.8. Synthesis of labeled peptides for binding assays
Peptides were synthesized using conventional Fmoc chemistry
on an Applied Biosystems Model 431A Peptide Synthesizer. The
synthesized peptides were split into two batches. The ¢rst batch
remained unlabeled, while a second batch was carried through an
additional synthetic cycle to add an N-terminal Cys. All cleaved
peptides were characterized by matrix-assisted laser desorption
ionization-time of £ight and puri¢ed on high performance liquid
chromatography (HPLC) prior to use.
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Either NK-(3-maleimidylpropionyl)biocytin or £uorescein-5-
maleimide (Molecular Probes, Eugene, OR, USA) was linked to
the free thiol of the N-terminal Cys, using a three times molar
excess of maleimide and ca. 1 mg of peptide. The maleimide
probe was dissolved in DMSO to 10 mg/ml and the peptide
was dissolved in 20 mM Tris, pH 7.0 to 1 mg/ml in a microfuge
tube. The Cys-containing peptides were handled in degassed re-
action bu¡ers and lyophilized from tri£uoroacetic acid solutions
to maintain the free thiol. After mixing the peptide and malei-
mide reagents, precipitation occurred in some cases; for those
mixtures, the reaction was centrifuged at 16 000Ug for 2 min,
and the reaction supernatant was removed and recombined
with the DMSO-redissolved precipitate. After shaking for 12 h
at room temperature, the conjugated peptides were puri¢ed by
HPLC.
5.9. Preparation of low molecular weight HA
Bacterially expressed HA (700^1200 kDa) was dissolved over-
night in 50 mM sodium acetate bu¡er (pH 6.0) to give a 4 mg/ml
solution. Ten units of testicular HAse (Sigma) per mg HA were
added to the solution and the reaction was shaken for 12 h
at 37‡C. An additional aliquot of HAse was added and the
solution was again incubated at 37‡C for 12 h. This material
was boiled for 5 min to inactivate any remaining HAse, and
particulate matter was removed by centrifugation. The molecular
weight was analyzed using gel permeation chromatography
(Waters), which showed a distribution of molecular sizes from
4 to 40 kDa. This material was employed in the binding as-
says.
5.10. Solid-phase binding assay
GST^RHAMM(518^580) was immobilized in a 96-well plate
(Greiner GmbH) and either bHA or biotinylated peptides were
added. Bound probes were detected using SA^HRP and the col-
orimetric HRP substrate 3,3P,5P,5-tetramethylbenzidine (TMB).
Thus, 50 Wl of 0.5 mg/ml GST^RHAMM(518^580) in 50 mM
Tris (pH 8.0) was incubated in each well for 1 h at 4‡C with
shaking. The wells were washed with TBS-T (20 mM Tris, 130
mM NaCl, pH 7.6, 0.1% Tween) three times, and then blocked
with TBS-T^PVP-40 (TBS-T+0.1% PVP-40) for 2 h at 4‡C. Di-
lutions of biotinylated probe (either HA or peptide) were added
to each well in 50 Wl TBS-T^PVP-40. After incubation for 45 min,
wells were washed with TBS-T and bound biotinylated probes
were detected using 50 Wl 0.5 Wg/ml SA^HRP (40 min, room
temperature). After three washes, 50 Wl TMB was added and
color was detected after 10 min using a Perkin Elmer HTS-
7000 microplate reader with the absorbance ¢lter set at 360 nm.
Experiments were performed in triplicate, and background was
measured using a biotinylated probe that was added to blocked
wells lacking GST^RHAMM(518^580). Control experiments in-
cluded measuring binding with the negative control peptide NB.
Alternatively, this experiment was performed using £uorescein-
labeled peptides rather than biotinylated peptides. In this case,
after the incubation step with £uorescein-labeled probes, the plate
was washed three times with TBS-T and then 50 Wl TBS was
added to each well. The plate was then read on the microplate
reader using 485 nm excitation and 535 nm emission ¢lters. The
gain was set to optimal and 50 £ashes were used to improve
sensitivity.
5.11. FP binding assay
Puri¢ed GST^RHAMM(518^580) was prepared at a stock con-
centration of 1.3 mg/ml (40 WM), and the initial concentration of
£uorescent peptide was 0.1 WM. Thus, 200 Wl of each dilution of
GST^RHAMM(518^580) was added to the wells of a low-bind
96-well plate with black sides and a clear bottom (Corning Co-
star). For each set of experiments, the £uorescein-labeled probe
concentration was kept constant, while the concentration of pro-
tein was incremented. Data were collected using a Polarion (Te-
can Inc.) microplate spectro£uorimeter equipped with a 485 nm
excitation ¢lter and a 585 nm emission ¢lter. Fifty £ashes were
used to achieve optimal sensitivity, and free £uorescein was used
as a standard at a value of 20 mP (millipolarization units). To
generate a binding isotherm, a plate was prepared with triplicates
of each concentration, serial dilutions of GST^RHAMM(518^
580) optimally covering the range from 20-fold below the KD
to approximately 100-fold above the KD. Identical aliquots of
£uorescein^peptide were added to each well, the solutions were
thoroughly mixed, the plate was incubated until equilibration was
reached, and then the £uorescence anisotropy was measured. The
binding data, mP values, and receptor concentrations were used
to calculate the binding constants. This assay is most useful for
probes that bind with KD values 6 1 WM, which constitutes a
practical limit of protein concentrations needed to generate the
isotherm.
FP data were analyzed as described [43,59] to measure the
amount of ligand bound by measurement of the anisotropy of
the complex. The total change in polarization is calculated as
vmP = mPmax3mPmin. The bound ligand at each concentration
is calculated as BT = [(mP3mPmin)(total tracer concentration)]/
vmP. Assuming 1:1 stoichiometry, BT = Rbound, and free
[HABD] can be calculated as Rfree = Rtot3Rbound. Scatchard anal-
ysis by plotting Rbound/Rfree vs. Rbound led to a best-¢t line with a
slope equal to the negative reciprocal of the KD [43].
5.12. Competition experiments using a £uorescence-based
solid-phase binding assay
Competition experiments were performed as outlined above
except the blocking bu¡er included 1 mg/ml competitor. The
wells were pre-incubated with competitor, and the biotinylated
or £uorescein-labeled probe was added together with competitor.
Digested HA was used for competition. Heparin, CS-A, and CS-
C were dissolved in H2O to 10 mg/ml, and were diluted to
1 mg/ml in TBS-T^PVP-40 in the competition experiments.
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